You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 14, 2025

Drug Price Trends for AYUNA-28 TABLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for AYUNA-28 TABLET

Average Pharmacy Cost for AYUNA-28 TABLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
AYUNA-28 TABLET 65862-0848-88 0.11613 EACH 2025-04-23
AYUNA-28 TABLET 65862-0848-28 0.11613 EACH 2025-04-23
AYUNA-28 TABLET 65862-0848-88 0.11918 EACH 2025-03-19
AYUNA-28 TABLET 65862-0848-28 0.11918 EACH 2025-03-19
AYUNA-28 TABLET 65862-0848-88 0.10957 EACH 2025-02-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Ayuna-28 Tablets

Introduction to Ayuna-28 Tablets

Ayuna-28 tablets are a combination oral contraceptive (COC) containing 0.15 mg of levonorgestrel and 0.03 mg of ethinyl estradiol, along with 7 inert tablets. This medication is indicated for the prevention of pregnancy and is available in various packaging options[1][5].

Market Context

The market for oral contraceptives is part of the broader pharmaceutical industry, which is experiencing significant growth driven by technological advancements, evolving regulatory frameworks, and a shift towards patient-centered care.

Biopharma and Biotech Industry Growth

The biopharma market, which includes oral contraceptives, was estimated to be over $400 billion in 2024, with a projected compound annual growth rate (CAGR) of 7.56% between 2024 and 2029. The biotech sector, closely related to pharmaceuticals, had a market size of nearly $500 billion in 2020 and is expected to grow at a CAGR of 9.4% between 2021 and 2027[3].

Pricing and Cost Considerations

Current Pricing

Ayuna-28 tablets, like other prescription medications, are subject to various pricing tiers and insurance coverage. For instance, under certain health plans, such as Aetna’s Assure Premier Plus, oral contraceptives may be covered with minimal or no out-of-pocket costs, depending on the specific plan and tier[2].

Factors Influencing Pricing

Several factors influence the pricing of Ayuna-28 tablets:

  • Regulatory Environment: Changes in regulatory frameworks can impact the cost of production and distribution, thereby affecting the final price to consumers[3].
  • Market Competition: The presence of other oral contraceptives in the market can drive competition, potentially leading to more competitive pricing.
  • Insurance Coverage: The extent of coverage provided by health insurance plans significantly affects the out-of-pocket costs for consumers.

Price Projections

General Trends

Given the stable demand for oral contraceptives and the overall growth in the pharmaceutical market, it is likely that the price of Ayuna-28 tablets will remain relatively stable or experience modest increases.

Impact of Generic and Biosimilar Competition

While Ayuna-28 is a branded product, the introduction of generic or biosimilar versions of similar oral contraceptives could potentially reduce prices due to increased competition. However, as of now, there is no indication of significant generic competition for Ayuna-28.

Market Analysis

Demand and Usage

The demand for oral contraceptives remains consistent due to their essential role in reproductive health. Ayuna-28, with its specific formulation and brand recognition, maintains a niche in this market.

Competitive Landscape

The market for oral contraceptives is highly competitive, with numerous brands and formulations available. Ayuna-28 competes with other combination oral contraceptives, each with its own strengths and patient preferences.

Future Outlook

Technological and Regulatory Changes

As the biopharma and biotech industries evolve, there may be innovations in drug delivery systems or new formulations that could impact the market for oral contraceptives. Regulatory changes could also influence the pricing and availability of these medications[3].

Patient-Centered Care

The shift towards patient-centered care and personalized medicine may lead to more tailored contraceptive options, potentially affecting the market share of Ayuna-28 and similar products.

Key Takeaways

  • Stable Demand: The demand for oral contraceptives like Ayuna-28 is expected to remain stable.
  • Pricing Stability: Prices are likely to remain relatively stable, with potential for modest increases.
  • Regulatory and Technological Impact: Future changes in regulations and technological advancements could influence pricing and market dynamics.
  • Competition: The introduction of generic or biosimilar versions could impact pricing and market share.

FAQs

Q: What are the active ingredients in Ayuna-28 tablets? A: Ayuna-28 tablets contain 0.15 mg of levonorgestrel and 0.03 mg of ethinyl estradiol[1][5].

Q: How are Ayuna-28 tablets packaged? A: Ayuna-28 tablets are available in cartons of 3 or 6 pouches, each containing 28 tablets (21 active and 7 inert tablets)[1].

Q: What is the typical cost of Ayuna-28 tablets under health insurance plans? A: The cost can vary, but under some plans, it may be covered with minimal or no out-of-pocket costs[2].

Q: Are there any generic versions of Ayuna-28 available? A: As of now, there is no significant generic competition for Ayuna-28.

Q: How do regulatory changes affect the pricing of Ayuna-28 tablets? A: Regulatory changes can impact production and distribution costs, which may affect the final price to consumers[3].

Sources

  1. RxList: Ayuna Tablets (Levonorgestrel and Ethinyl Estradiol) - RxList
  2. Aetna Better Health: 2024 Aetna® Assure Premier Plus (HMO D-SNP) List of Covered Drugs
  3. TFS CRO: 5 Predictions for the Biopharma and Biotech Industries in 2025
  4. Drug Development: NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025
  5. Drugs.com: Ayuna: Package Insert / Prescribing Information - Drugs.com
Last updated: 2025-01-02

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.